Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer

Journal of Thoracic Oncology

Volumn 7, Issue 10, 2012, Pages 1485-1489

  Morgensztern, Daniel ^a   Waqar, Saiama ^b   Subramanian, Janakiraman ^b,c   Trinkaus, Kathryn ^b   Govindan, Ramaswamy ^b,c  

^a YALE CANCER CENTER   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MO   (United States)

Author keywords

Lung cancer; Malignant pleural effusion; Stage IV

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; DISTANT METASTASIS; FEMALE; HAZARD RATIO; HISTOPATHOLOGY; HUMAN; KAPLAN MEIER METHOD; LOGISTIC REGRESSION ANALYSIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PLEURA EFFUSION; PRIORITY JOURNAL; PROBABILITY; PROPORTIONAL HAZARDS MODEL;

EID: 84866631390     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318267223a     Document Type: Article

References (14)

1. Heffner JE, Klein JS. Recent advances in the diagnosis and management of malignant pleural effusions. Mayo Clin Proc 2008;83:235-250. (Pubitemid 351303104)
2. Management of malignant pleural effusions. Am J Respir Crit Care Med 2000; 162:1987-2001.
3. Antunes G, Neville E, Duffy J, et al.: BTS guidelines for the management of malignant pleural effusions. Thorax 2003;58 Suppl 2:ii29-ii38. (Pubitemid 36561106)
4. Cohen S, Hossain SA. Primary carcinoma of the lung. A review of 417 histologically proved cases. Dis Chest 1966;49:67-74.
5. Emerson GL, Emerson MS, Sherwood CE. The natural history of carcinoma of the lung. J Thorac Surg 1959;37:291-304.
6. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-1717. (Pubitemid 27260107)
7. Goldstraw P, Crowley J, Chansky K, et al.; International Association for the Study of Lung Cancer International Staging Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007;2:706-714. (Pubitemid 47357522)
8. Sahn SA. The pathophysiology of pleural effusions. Annu Rev Med 1990;41:7-13. (Pubitemid 20121709)
9. Lynch TJ Jr. Management of malignant pleural effusions. Chest 1993;103:385S-389S. (Pubitemid 23110360)
10. Meyer PC. Metastatic carcinoma of the pleura. Thorax 1966;21:437-443.
11. Irani DR, Underwood RD, Johnson EH, Greenberg SD. Malignant pleural effusions. A clinical cytopathologic study. Arch Intern Med 1987;147:1133-1136. (Pubitemid 17113279)
12. Chernow B, Sahn SA. Carcinomatous involvement of the pleura: an analysis of 96 patients. Am J Med 1977;63:695-702. (Pubitemid 8222934)
13. Ou SH, Zell JA. Carcinoma NOS is a common histologic diagnosis and is increasing in proportion among non-small cell lung cancer histologies. J Thorac Oncol 2009;4:1202-1211.
14. Rami-Porta R, Ball D, Crowley J, et al.; International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2007;2:593-602. (Pubitemid 47171780)